Covered recipient · General Payments record
ANETTE GARCES DOMINGUEZ
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$21,439.04
- Reported across 1,188 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $396.72 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $192.46 | 12 |
| Lilly USA, LLC | $118.73 | 1 |
| Amgen Inc. | $50.28 | 2 |
| Novo Nordisk AS | $18.53 | 1 |
| Abbott Laboratories | $16.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.72 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124983435 | CMS |
| Amgen Inc. | $23.49 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111580321 | CMS |
| Amgen Inc. | $26.79 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111580323 | CMS |
| Dexcom, Inc. | $4.88 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279701 | CMS |
| Dexcom, Inc. | $9.72 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279703 | CMS |
| Dexcom, Inc. | $7.18 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279705 | CMS |
| Dexcom, Inc. | $8.96 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279707 | CMS |
| Dexcom, Inc. | $10.59 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279709 | CMS |
| Dexcom, Inc. | $3.29 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279711 | CMS |
| Dexcom, Inc. | $121.20 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279723 | CMS |
| Dexcom, Inc. | $6.05 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279715 | CMS |
| Dexcom, Inc. | $2.89 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279713 | CMS |
| Dexcom, Inc. | $3.90 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279717 | CMS |
| Dexcom, Inc. | $6.26 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279719 | CMS |
| Dexcom, Inc. | $7.54 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279721 | CMS |
| Lilly USA, LLC | $118.73 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136040382 | CMS |
| Novo Nordisk Inc | $18.53 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096564257 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.